• Explore /
  • Poster
  • / DIsCOvER: A multicenter, randomized, double-blind, placebo-controlled, phase III clinical trial to investigate the efficacy and safety of dronabinol in the improvement of chemotherapy-induced and tumor-related symptoms in patients with locally advanced or metastatic pancreas cancer during first-line chemotherapy.

DIsCOvER: A multicenter, randomized, double-blind, placebo-controlled, phase III clinical trial to investigate the efficacy and safety of dronabinol in the improvement of chemotherapy-induced and tumor-related symptoms in patients with locally advanced or metastatic pancreas cancer during first-line chemotherapy.

Abstract Poster

Authors

null

Felix Keil

Hanusch-Krankenhaus Verein für Leukämieforschung, Wein, Germany

Felix Keil , Georg Schreil , Thamer Sliwa , Meinolf Karthaus , Adelheid Seebacher , Harald Werner Weiss , Beate Mayrbaeurl , Rudolf Likar , Ewald Woell , Claudio Denzlinger , Richard Greil

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Quality of Care/Quality Improvement

Clinical Trial Registration Number

NCT03984214

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr TPS711)

DOI

10.1200/JCO.2024.42.3_suppl.TPS711

Abstract #

TPS711

Poster Bd #

P20

Abstract Disclosures

Similar Posters

First Author: Kazuo Watanabe

First Author: Hiroyuki Asama

First Author: Akihiro Ohba

First Author: Peter Schmid